Recent Performance Dip: Astrana Health (ASTH) has seen a notable decline in its stock price over the past six months, with shares dropping to around $29.02, marking a 14.8% loss compared to the S&P 500’s strong gains. Discussions on X have highlighted investor concerns about this underperformance, with some questioning the company’s short-term outlook. There’s a mix of frustration and curiosity about potential recovery catalysts.
Strategic Moves in Focus: Posts on X have also pointed to Astrana Health’s ongoing efforts in value-based care and tech-driven healthcare management as potential positives. Some users are intrigued by the company’s strategic partnerships and upcoming earnings reports, hoping for a turnaround. The chatter reflects a cautious interest in whether these initiatives can reverse recent trends.
Note: This discussion summary was generated from an AI condensation of post data.
Astrana Health Congressional Stock Trading
Members of Congress have traded $ASTH stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ASTH stock by members of Congress over the last 6 months:
- REPRESENTATIVE JUDY CHU has traded it 2 times. They made 1 purchase worth up to $250,000 on 08/19 and 1 sale worth up to $250,000 on 08/19.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Astrana Health Hedge Fund Activity
We have seen 85 institutional investors add shares of Astrana Health stock to their portfolio, and 92 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 339,689 shares (-22.2%) from their portfolio in Q2 2025, for an estimated $8,451,462
- BLACKROCK, INC. removed 287,543 shares (-4.6%) from their portfolio in Q2 2025, for an estimated $7,154,069
- ATRIA WEALTH SOLUTIONS, INC. removed 237,370 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $5,905,765
- JACOBS LEVY EQUITY MANAGEMENT, INC added 182,136 shares (+76.6%) to their portfolio in Q2 2025, for an estimated $4,531,543
- PACER ADVISORS, INC. added 181,910 shares (+inf%) to their portfolio in Q3 2025, for an estimated $5,157,148
- MORGAN STANLEY added 165,053 shares (+48.1%) to their portfolio in Q2 2025, for an estimated $4,106,518
- BELLEVUE GROUP AG removed 163,155 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,059,296
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
